Balyasny Asset Management LLC Adma Biologics, Inc. Transaction History
Balyasny Asset Management LLC
- $61.9 Billion
- Q2 2025
A detailed history of Balyasny Asset Management LLC transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Balyasny Asset Management LLC holds 971,414 shares of ADMA stock, worth $14.9 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
971,414
Previous 381,707
154.49%
Holding current value
$14.9 Million
Previous $7.57 Million
133.58%
% of portfolio
0.03%
Previous 0.01%
Shares
8 transactions
Others Institutions Holding ADMA
# of Institutions
399Shares Held
191MCall Options Held
2.08MPut Options Held
1.56M-
Vanguard Group Inc Valley Forge, PA21.4MShares$327 Million0.01% of portfolio
-
Black Rock Inc. New York, NY18.6MShares$285 Million0.0% of portfolio
-
Invesco Ltd. Atlanta, GA12.8MShares$196 Million0.04% of portfolio
-
State Street Corp Boston, MA12.1MShares$185 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA5.91MShares$90.4 Million0.01% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $3B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...